Where Cures Thrive.
We're on a mission to transform the biomanufacturing sector through the creation and delivery of a new Plug and Manufacture solution. GeneSuites will provide an ecosystem where cures thrive for patients, patient families, and future generations.
Accelerating Speed to Market with High-Performance Shell
GeneSuites offers a novel solution for biopharmaceutical companies to accelerate speed to market while minimizing risk. Our High-Performance Shell structure offers both the flexibility of a cold shell combined with the optionality of turnkey real estate.
Speed to Market
Unprecedented approach to building flexible and equipped cGMP facilities that can easily adapt to new modalities and processes
Through a hybrid approach, maintain total control of manufacturing process and environment
Eliminate the need for contracting with third-parties (CDMO/CMOs) and revealing methodologies
Reduce cost per batch / dose through optimized operations
Ability to accommodate multiple therapies, processes and technologies within the same facility
Can accommodate pre-clinical through commercial scale
Major Life Science Clusters
GeneSuites has entered the Raleigh-Durham market with Catalyst BioCampus and will continue to expand across major life science markets in the United States and abroad.
First of its Kind:
High-Performance Shell in North Carolina
In partnership with affiliates of Apollo Global Management, GeneSuites is developing Catalyst BioCampus, a three-building cGMP biomanufacturing campus located in Raleigh-Durham, NC.
Already under construction, Catalyst BioCampus is designed to accelerate critical manufacturing capacity for cell & gene therapy, monoclonal antibody – as well as other modalities – by 9-15 months.